Edgestream Partners L.P. reduced its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 70.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,612 shares of the real estate investment trust's stock after selling 37,783 shares during the quarter. Edgestream Partners L.P.'s holdings in National Health Investors were worth $1,153,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the business. Xponance Inc. boosted its stake in shares of National Health Investors by 11.2% during the 1st quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust's stock valued at $246,000 after buying an additional 337 shares during the last quarter. DekaBank Deutsche Girozentrale raised its position in National Health Investors by 4.3% in the first quarter. DekaBank Deutsche Girozentrale now owns 55,482 shares of the real estate investment trust's stock worth $4,076,000 after acquiring an additional 2,273 shares in the last quarter. M&T Bank Corp boosted its position in shares of National Health Investors by 4.4% in the 1st quarter. M&T Bank Corp now owns 3,969 shares of the real estate investment trust's stock valued at $293,000 after purchasing an additional 168 shares during the period. Bank of New York Mellon Corp boosted its stake in National Health Investors by 5.6% in the 1st quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust's stock worth $43,494,000 after purchasing an additional 31,451 shares during the period. Finally, Aviance Capital Partners LLC lifted its stake in National Health Investors by 16.3% in the 1st quarter. Aviance Capital Partners LLC now owns 5,036 shares of the real estate investment trust's stock worth $372,000 after acquiring an additional 706 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
National Health Investors Stock Performance
NHI stock traded up $1.15 during trading on Tuesday, hitting $71.30. The company had a trading volume of 175,235 shares, compared to its average volume of 253,155. The firm has a 50-day moving average price of $71.82 and a 200-day moving average price of $71.73. National Health Investors, Inc. has a 1-year low of $65.13 and a 1-year high of $86.13. The company has a quick ratio of 16.55, a current ratio of 16.55 and a debt-to-equity ratio of 0.88. The firm has a market cap of $3.33 billion, a PE ratio of 22.63, a price-to-earnings-growth ratio of 3.54 and a beta of 0.73.
National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. The company had revenue of $68.87 million for the quarter, compared to analyst estimates of $85.13 million. National Health Investors had a return on equity of 10.64% and a net margin of 41.15%. The firm's revenue was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $1.10 earnings per share. On average, analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be given a dividend of $0.90 per share. The ex-dividend date is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a yield of 5.05%. National Health Investors's payout ratio is presently 114.29%.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price on the stock in a report on Thursday, July 10th. Wedbush upgraded National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. Finally, Truist Financial upgraded shares of National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 price target on the stock in a research report on Wednesday, July 2nd. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $84.60.
Check Out Our Latest Stock Report on National Health Investors
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.